Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?



Rating:

Share or cite this content

Citations should be made in the following way:
Christopher Jungnickel (Homburg, Germany), Christopher Jungnickel, Philipp Schnabel, Rainer Bohle, Robert Bals, Christoph Beisswenger. COPD-like inflammation drives the progression of K-ras induced early cancerous lesions. Eur Respir J 2016; 48: Suppl. 60, 520

Member's Comments

No comment yet.

Related content which might interest you: Promotion of lung cancer progression by COPD-like chronic inflammation in a mouse model Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 RBM5 regulates EGFR involving in cancerous transformation of cigarette smoke-induced BEAS-2B cells Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome in resected non-small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 IL-17C promotes tumor-associated inflammation and lung tumor growth Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 MET genetic lesions in NSCLC are functional markers of early hematogenous spreading and radioresistance Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Deciphering the link between COPD and lung cancer: Cigarette smoke-induced immunosuppression at the crossroads between cancer immune surveillance and escape Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Chemokines CXCL12 and CCL21 may contribute to the development of lung cancer in COPD patients Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Correlation between EGFR mutations and emphysematous changes in heavy smokers with lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001 Prevalence of molecular changes in resected pulmonary adenocarcinomas Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Prevalence of preinvasive bronchial lesions in patients with lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 LATE-BREAKING ABSTRACT: The role of eosinophils in Kras-G12D induced lung tumor initiation and progression Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 A requirement for IKKa in lung adenocarcinoma Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015